Luisa Giannangelo, MBA, RPh

home / authors / luisa-giannangelo-mba-rph

Articles

Chronic lymphocytic leukemia -- Image credit: LASZLO | stock.adobe.com

Chronic Lymphocytic Leukemia: A Review of Noncovalent BTK Inhibitors, Novel Agents, and Toxicity Management of BTK Inhibitors

Richa Shah, PharmD, BCOP;Jessie Modlin, PharmD, BCOP;Rezarta Lako, PharmD, BCPS;Yuxi Lei, PharmD;Adina Kagan, PharmD Candidate;Cradesha Perry, PharmD, MBA;Luisa Giannangelo, MBA, RPh;Rebecca Pokorny, PharmD, BCPS, BCOP;Kevin Pang, PharmD
August 19th 2024

This article discusses clinical data for noncovalent Bruton tyrosine kinase inhibitors (BTKis), novel strategies in CLL, and the practical management of BTKi toxicities.

Read More

CLL in blood -- Image credit: Dr_Microbe | stock.adobe.com

Covalent BTK Inhibitors: A Review of the Evidence in Chronic Lymphocytic Leukemia

Richa Shah, PharmD, BCOP;Rebecca Pokorny, PharmD, BCPS, BCOP;Luisa Giannangelo, MBA, RPh;Cradesha Perry, PharmD, MBA;Adina Kagan, PharmD Candidate;Yuxi Lei, PharmD;Rezarta Lako, PharmD, BCPS;Jessie Modlin, PharmD, BCOP;Kevin Pang, PharmD
June 14th 2024

This article provides an overview of data supporting the utility of covalent Bruton tyrosine kinase inhibitors in chronic lymphocytic leukemia and details important considerations when choosing among agents.

Read More

Lymphoma diagnosis -- Image credit: tashatuvango | stock.adobe.com

Novel Combination Therapies in Relapsed/ Refractory Classical Hodgkin Lymphoma

Valassia Antigone "Noni" Theocharides, PharmD Candidate;Luisa Giannangelo, MBA, RPh;Jessie Modlin, PharmD, BCOP;Tesnim Shash, PharmD Candidate;Sukeina Nasser, PharmD, CPh, PACS
February 23rd 2024

Data shed light on brentuximab vedotin plus nivolumab, bendamustine, or gemcitabine.

Read More

Phogomicrograph of pulmonary (lung) nodule showing adenocarcinoma, a type of non small cell carcinoma

Recent Clinical Trials Reveal Important Updates in Adjuvant Therapy for Resectable Non–Small Cell Lung Cancer

Yuxi Lei, PharmD;Rebecca Pokorny, PharmD, BCPS, BCOP;Luisa Giannangelo, MBA, RPh
October 20th 2023

Integrating immunotherapies will continue to improve patient outcomes and quality of life.

Read More

Latest Updated Articles

raw vegetables with blood glucose meter, syringe, lancet and stethoscope on desk, diabetes healthy diet concept - Image credit: neirfy | stock.adobe.com
Published: June 12th 2025 | Updated: June 16th 2025
Study: How Individual Carbohydrate Responses Reveal Metabolic Health and Potential Biomarkers
Milan, Italy - APRIL 10, 2021: CDC logo on laptop screen seen through an optical prism. Illustrative editorial image from CDC website.
Published: June 10th 2025 | Updated: June 12th 2025
Department of Health and Human Services Reconstitutes ACIP, Removing 17 Sitting Members
NLA 2025: Managing Omega-3 Therapy With Statins, PCSK9 Inhibitors for Cardiovascular Care
Published: June 2nd 2025 | Updated: June 11th 2025
NLA 2025: Managing Omega-3 Therapy With Statins, PCSK9 Inhibitors for Cardiovascular Care
Image credit: catalin | stock.adobe.com
Published: June 3rd 2025 | Updated: June 11th 2025
ASCO 2025: Zongertinib Shows Strong Potential in HER2-Mutant NSCLC Treatment Landscape
Emerging Data: Impacts of ROCKstar and AGAVE-201
Published: May 30th 2025 | Updated: June 5th 2025
Emerging Data: Impacts of ROCKstar and AGAVE-201
Mother holding baby's foot with measles spots | Image Credit: © rostock-studio - stock.adobe.com
Published: April 18th 2025 | Updated: April 21st 2025
Measles Cases Climb to 800 in United States as Outbreak Spreads Across Borders
© 2025 MJH Life Sciences

All rights reserved.